TechFlow news, December 20 — According to GlobeNewswire, Quantum BioPharma Ltd. (Nasdaq: QNTM), a biopharmaceutical company, announced that it has purchased $1 million worth of Bitcoin and other cryptocurrencies, approved by the board of directors, as part of its strategic initiatives.
The company is now prepared to accept financing in cryptocurrency and to conduct other types of cryptocurrency transactions. All of the company’s cryptocurrencies are held in custody by a fully compliant custodian. The company emphasized that all transactions, both current and future, will fully comply with all relevant financial and auditing regulations, ensuring security and legality.
The company will continue to monitor market conditions and may increase or decrease its holdings in Bitcoin (BTC) or other cryptocurrencies as it deems appropriate.
